Characterization of Infiltrating Immune Cells and Secretory or Membrane-Associated Proteins in KRAS Lung Adenocarcinoma

被引:1
作者
Bian, Yunyi [1 ]
Bi, Guoshu [1 ]
Shan, Guangyao [1 ]
Liang, Jiaqi [1 ]
Sui, Qihai [1 ]
Hu, Zhengyang [1 ]
Wang, Qun [1 ]
Zhang, Yi [1 ]
Fan, Hong [1 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai, Peoples R China
关键词
INHIBITION; EXPRESSION; PROGNOSIS; CARCINOMA; EFFICACY; BIOLOGY; REVEAL; LASSO;
D O I
10.1155/2023/4987832
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. This study identified the expression and prognosis significance of secretory or membrane-associated proteins in KRAS lung adenocarcinoma (LUAD) and depicted the characteristics between the immune cell infiltration and the expression of these genes. Methods. Gene expression data of LUAD samples (n=563) were accessed from The Cancer Genome Atlas (TCGA). The expression of secretory or membrane-associated proteins was compared among the KRAS-mutant, wild-type, and normal groups, as well as the subgroup of the KRAS-mutant group. We identified the survival-related differentially expressed secretory or membrane-associated proteins and conducted the functional enrichment analysis. Then, the characterization and association between their expression and the 24 immune cell subsets were investigated. We also constructed a scoring model to predict KRAS mutation by LASSO and logistic regression analysis. Results. Secretory or membrane-associated genes with differential expression (n=74) across three groups (137 KRAS LUAD, 368 wild-type LUAD, and 58 normal groups) were identified, and the results of GO and KEGG indicated that they were strongly associated with immune cell infiltrations. Among them, ten genes were significantly related to the survival of patients with KRAS LUAD. The expression of IL37, KIF2, INSR, and AQP3 had the most significant correlations with immune cell infiltration. In addition, eight DEGs from the KRAS subgroups were highly correlated with immune infiltrations, especially TNFSF13B. Using LASSO-logistic regression, a KRAS mutation prediction model based on the 74 differentially expressed secretory or membrane-associated genes was built, and the accuracy was 0.79. Conclusion. The research investigated the relationship between the expression of KRAS-related secretory or membrane-associated proteins in LUAD patients with prognostic prediction and immune infiltration characterization. Our study demonstrated that secretory or membrane-associated genes were closely associated with the survival of KRAS LUAD patients and were strongly correlated to immune cell infiltration.
引用
收藏
页数:12
相关论文
共 51 条
  • [1] KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition
    Adderley, Helen
    Blackhall, Fiona H.
    Lindsay, Colin R.
    [J]. EBIOMEDICINE, 2019, 41 : 711 - 716
  • [2] Detection of RAS genes mutation using the Cobas ® method in a private laboratory of pathology: Medical and economical study in comparison to a public platform of molecular biology of cancer
    Albertini, Anne-Flore
    Raoux, Delphine
    Neumann, Frederic
    Rossat, Stephane
    Tabet, Farid
    Pedeutour, Florence
    Duranton-Tanneur, Valerie
    Kubiniek, Valerie
    Vire, Olivier
    Weinbreck, Nicolas
    [J]. BULLETIN DU CANCER, 2017, 104 (7-8) : 662 - 674
  • [3] Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis
    Bi, Guoshu
    Chen, Zhencong
    Yang, Xiaodong
    Liang, Jiaqi
    Hu, Zhengyang
    Bian, Yunyi
    Sui, Qihai
    Li, Runmei
    Zhan, Cheng
    Fan, Hong
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (07) : 1293 - 1305
  • [4] Integrative genome-scale analysis of immune infiltration in esophageal carcinoma
    Bian, Yunyi
    Bi, Guoshu
    Wei, Tengteng
    Yao, Guangyu
    Chen, Zhencong
    Zhan, Cheng
    Fan, Hong
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 93
  • [5] Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
    Bindea, Gabriela
    Mlecnik, Bernhard
    Tosolini, Marie
    Kirilovsky, Amos
    Waldner, Maximilian
    Obenauf, Anna C.
    Angell, Helen
    Fredriksen, Tessa
    Lafontaine, Lucie
    Berger, Anne
    Bruneval, Patrick
    Fridman, Wolf Herman
    Becker, Christoph
    Pages, Franck
    Speicher, Michael R.
    Trajanoski, Zlatko
    Galon, Jerome
    [J]. IMMUNITY, 2013, 39 (04) : 782 - 795
  • [6] The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
    Bruni, Daniela
    Angell, Helen K.
    Galon, Jerome
    [J]. NATURE REVIEWS CANCER, 2020, 20 (11) : 662 - 680
  • [7] Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
    Charoentong, Pornpimol
    Finotello, Francesca
    Angelova, Mihaela
    Mayer, Clemens
    Efremova, Mirjana
    Rieder, Dietmar
    Hackl, Hubert
    Trajanoski, Zlatko
    [J]. CELL REPORTS, 2017, 18 (01): : 248 - 262
  • [8] Microtubule polymerization dynamics
    Desai, A
    Mitchison, TJ
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1997, 13 : 83 - 117
  • [9] TIM-3 restrains anti-tumour immunity by regulating inflammasome activation
    Dixon, Karen O.
    Tabaka, Marcin
    Schramm, Markus A.
    Xiao, Sheng
    Tang, Ruihan
    Dionne, Danielle
    Anderson, Ana. C.
    Rozenblatt-Rosen, Orit
    Regev, Aviv
    Kuchroo, Vijay K.
    [J]. NATURE, 2021, 595 (7865) : 101 - +
  • [10] PD-L1 as a biomarker of response to immune-checkpoint inhibitors
    Doroshow, Deborah Blythe
    Bhalla, Sheena
    Beasley, Mary Beth
    Sholl, Lynette M.
    Kerr, Keith M.
    Gnjatic, Sacha
    Wistuba, Ignacio I.
    Rimm, David L.
    Tsao, Ming Sound
    Hirsch, Fred R.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (06) : 345 - 362